Characterization of the immune response induced by pertussis OMVs-based vaccine.

ZURITA MARÍA EUGENIA; BARTEL ERIKA; ERREA AGUSTINA; DANIELA F. HOZBOR,; ZURITA MARÍA EUGENIA; BARTEL ERIKA; ERREA AGUSTINA; GAILLARD MARÍA EMILIA; DANIELA F. HOZBOR,; MORENO GRISELDA; SOL BRAVO; CASTUMA CELINA; GAILLARD MARÍA EMILIA; MORENO GRISELDA; BOTTERO DANIELA; SOL BRAVO; DAVID SABATER MARTINEZ; CASTUMA CELINA; CARRIQUIRIBORDE FRANCISCO; RUMBO MARTÍN; BOTTERO DANIELA; DAVID SABATER MARTINEZ; CARRIQUIRIBORDE FRANCISCO; RUMBO MARTÍN

VACCINE

ELSEVIER SCI LTD

Lugar: Amsterdam; Año: 2016 p. 3303 - 3309

0264-410X

For the development of a third generation of pertussis vaccine that could improve the control of the disease, it was proposed that the immune responses induced by the classic whole cell vaccine (wP) or after infection should be used as a reference point. We have recently identified a vaccine candidate based on outer membrane vesicles (OMVs) derived from the disease etiologic agent that have been shown to be safe and protective in mice model of infection. Here we characterized OMVs-mediated immunity and the safety of our new candidate. We also deepen the knowledge of the induced humoral response contribution in pertussis protection. Regarding the safety of the OMVs based vaccine (TdapOMVsBp,) the in vitro whole blood human assay here performed, showed that the low toxicity of OMVs-based vaccine previously detected in mice could be extended to human samples. Stimulation of splenocytes from immunized mice evidenced the presence of IFN-γ and IL-17-producing cells, indicated that OMVs induces both Th1 and Th17 response. Interestingly TdapOMVsBp-raised antibodies such as those induced by wP and commercial acellular vaccines (aP) which contribute to induce protection against Bordetella pertussis infection. As occurs with wP-induced antibodies, the TdapOMVsBp-induced serum antibodies efficiently opsonized B. pertussis. All the data here obtained shows that OMVs based vaccine is able to induce Th1/Th17 and Th2 mixed profile with robust humoral response involved in protection, positioning this candidate among the different possibilities to constitute the third generation of anti-pertussis vaccines.